Overview
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
Eligibility
Inclusion Criteria:
- age greater than 18 years
- scheduled for an elective laparoscopic gastric bypass procedure
Exclusion Criteria:
- age less than 18 years
- pregnancy
- prisoners
- significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
- patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2>98%)